Minaris Regenerative Medicine GmbH, a contract development and manufacturing organization for cell and gene therapies, has implemented the newest version of Werum PAS-X MES by Körber, a digital Manufacturing Execution System (MES), at its German site in Ottobrunn near Munich—thereby converting its production
JERSEY CITY, NJ / ACCESSWIRE / September 6, 2023 / Apprentice.io, a leading technology provider for life sciences manufacturers, announced that Minaris Regenerative Medicine, a leading contract development and manufacturing organization (CDMO) focused on cell and gene therapies, has selected Apprentice's Tempo Manufacturing Execution System (MES) to digitize its commercial manufacturing in North America and Japan. Minaris will use Tempo MES to increase speed-to-market, reduce costs, and deliver a superior customer experience. These improvements will accelerate complex commercial batches so patients in need of cutting-edge cell and gene therapies can receive reliable treatment faster.